Table 1. Demographic and characteristics of Jab1 in lung cancer patients (n=88).

Variable	Total n=88	Low COPS5	High COPS5	p
Age
<60	39	13(33.3%)	26(66.7%)	0.249
≥60	49	12(24.5%)	37(75.5%)
Sex
Male	67	19(28.4%)	48(71.6%)	0.594
Female	21	6(28.6%)	15(71.4%)
Histological type
SCLC	31	13(41.9%)	18(58.1%)	0.035
NSCLC	57	12(21.1%)	45(78.9%)
Smoking
No	37	11(29.7%)	26(70.3%)	0.500
Yes	51	14(27.5%)	37(72.5%)
Stage
I	9	1(11.1%)	8(88.9%)	0.017
II	9	1(11.1%)	8(88.9%)
III	11	0(0%)	11(100%)
IV	59	23(39.0%)	36(61.0%)
Tumor size
T1	29	6(20.7%)	23(79.3%)	0.186
T2	44	13(29.5%)	31(70.5%)
T3	12	6(50.0%)	6(50.0%)
T4	3	0(0%)	3(100%)
LN metastasis
No	22	2(9.1%)	20(90.9)	0.016
Yes	66	23(34.8%)	43(65.2%)
Distant metastasis
No	37	5(13.5%)	32(86.5%)	0.007
Yes	51	20(39.2%)	31(60.8%)
Ki-67
<14%	2	1(50.0%)	1(50.0%)	0.490
≥14%	86	24(27.9%)	62(72.1%)
Hydrothorax
No	63	14(22.2%)	49(77.8%	0.039
Yes	25	11(40.0%)	14(56.0%)